Vaxil Bio Ltd (VXL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vaxil Bio Ltd (VXL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9429
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vaxil Bio Ltd (Vaxil Bio), formerly Emerge Resources Corp, is a drug development company that develops immunotherapy platform. The company’s immunptherapy pipeline products include antigen specific immunotherapies, signal peptide specific antibodies and anti-infectives. It develops Vaxhit technology platform that enables integrated identification, isolation and production of antigen specific immunotherapies targeting high-profile cancer antigens. Vaxil Bio also develops Immucin, a lead immunotherapy product for multiple myeloma cancer patients. The company operates its laboratory in Ness-Ziona, Israel. Vaxil Bio is headquartered in Toronto, Ontario, Canada.

Vaxil Bio Ltd (VXL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaxil Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaxil Bio Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Vaxil Biotherapeutics To Raise US$3 Million In Venture Financing 11
Partnerships 12
Vaxil Bio Enters into Agreement with Clalit Meir Medical Center 12
Vaxil Bio Enters Agreement with Hadassah Medical Centre 13
Vaxil Bio Enters Into Research Agreement With University of Santiago de Compostela 14
Equity Offering 15
Vaxil Bio Raises USD1.4 Million in Private Placement of Shares and Warrants 15
Vaxil-Bio Raises USD0.5 Million in Private Placement of Units 16
Vaxil Bio Raises Funds through Private Placement of Shares 17
Vaxil Bio Raises Funds through Private Placement of Shares 18
Acquisition 19
Emerge Resources Acquires Vaxil Bio in Reverse Takeover Transaction 19
Vaxil Bio Ltd – Key Competitors 20
Vaxil Bio Ltd – Key Employees 21
Vaxil Bio Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Sep 06, 2018: Vaxil Appoints veteran pharma executive David Goren as CEO 23
Dec 05, 2017: Vaxil Strengthens Board of Directors and Management Concurrent to $1-Million Financing 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaxil Bio Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaxil Bio Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Vaxil Bio Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vaxil Biotherapeutics To Raise US$3 Million In Venture Financing 11
Vaxil Bio Enters into Agreement with Clalit Meir Medical Center 12
Vaxil Bio Enters Agreement with Hadassah Medical Centre 13
Vaxil Bio Enters Into Research Agreement With University of Santiago de Compostela 14
Vaxil Bio Raises USD1.4 Million in Private Placement of Shares and Warrants 15
Vaxil-Bio Raises USD0.5 Million in Private Placement of Units 16
Vaxil Bio Raises Funds through Private Placement of Shares 17
Vaxil Bio Raises Funds through Private Placement of Shares 18
Emerge Resources Acquires Vaxil Bio in Reverse Takeover Transaction 19
Vaxil Bio Ltd, Key Competitors 20
Vaxil Bio Ltd, Key Employees 21
Vaxil Bio Ltd, Subsidiaries 22

List of Figures
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vaxil Bio Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vaxil Bio Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Vaxil Bio Ltd (VXL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cree, Inc.:企業の戦略・SWOT・財務分析
    Cree, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cree, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • E. Bon Holdings Limited (599):企業の財務・戦略的SWOT分析
    E. Bon Holdings Limited (599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Turboatom (TATM):企業の財務・戦略的SWOT分析
    Turboatom (TATM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Singapore Telecommunications Ltd:企業の戦略・SWOT・財務分析
    Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Showa Shell Sekiyu KK (5002):企業の財務・戦略的SWOT分析
    Showa Shell Sekiyu KK (5002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Samsung C&T Corp:企業のM&A・事業提携・投資動向
    Samsung C&T Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Samsung C&T Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • The Broad Institute Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Olympic Mountain and Marine Products, Inc.:企業の戦略・SWOT・財務情報
    Olympic Mountain and Marine Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Olympic Mountain and Marine Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • ProMIS Neurosciences Inc (PMN):企業の財務・戦略的SWOT分析
    ProMIS Neurosciences Inc (PMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Pancake House, Inc.:企業の戦略・SWOT・財務情報
    Pancake House, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pancake House, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HHV Solar Technologies Ltd:電力:M&Aディール及び事業提携情報
    Summary HHV Solar Technologies Ltd (HHV Solar), a subsidiary of Swelect Energy Systems Ltd, is a renewable energy company that manufactures and markets silicon photovoltaic solar modules. The company's modules include monocrystalline solar photovoltaic modules, multi-crystalline solar photovoltaic m …
  • Verizon Communications Inc (VZ):電力:M&Aディール及び事業提携情報
    Summary Verizon Communications Inc. (Verizon) provides communications, information and entertainment products and services. The company offers a comprehensive range of voice, data and video services and solutions through its wireless and wireline networks. Its multimedia offerings include music, vid …
  • Fujifilm Holdings Corp (FUJIY):企業の財務・戦略的SWOT分析
    Fujifilm Holdings Corp (FUJIY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Blirt SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Blirt SA (Blirt) is a biotechnology company that produces specialty enzymes utilized in nucleic acid for purification and sequencing. The company offers recombinant protein and molecular biology products. It provides protein products such as proteinases, RNase inhibitors, reverse transciptas …
  • Assicurazioni Generali SpA:戦略・SWOT・企業財務分析
    Assicurazioni Generali SpA - Strategy, SWOT and Corporate Finance Report Summary Assicurazioni Generali SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mitsubishi Logistics Corporation (9301):企業の財務・戦略的SWOT分析
    Mitsubishi Logistics Corporation (9301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Tesla Motors, Inc.:企業の戦略・SWOT・財務情報
    Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Toronto-Dominion Bank:企業の戦略・SWOT・財務情報
    The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report Summary The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Labco SA-製薬・医療分野:企業M&A・提携分析
    Summary Labco SA (Labco) is a medical diagnostic company that provides clinical laboratory services. The company provides detection and prevention of chronic and severe disorders. Its medical services include laboratory, internal analysis and transmission of internal results and diagnostic interpret …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆